SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-20-002598
Filing Date
2020-02-13
Accepted
2020-02-13 16:31:27
Documents
6
Period of Report
2020-02-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dmtp20200211_8k.htm 8-K 30306
2 EXHIBIT 1.1 ex_172265.htm EX-1.1 234190
3 EXHIBIT 5.1 ex_172266.htm EX-5.1 9823
4 EXHIBIT 99.1 ex_172268.htm EX-99.1 8938
5 logo01.jpg GRAPHIC 18167
6 logo02.jpg GRAPHIC 16793
  Complete submission text file 0001437749-20-002598.txt   332872
Mailing Address 2 CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447
Business Address 2 CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447 (763) 496-5454
DiaMedica Therapeutics Inc. (Filer) CIK: 0001401040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36291 | Film No.: 20611150
SIC: 2834 Pharmaceutical Preparations